Breast milk of people vaccinated against COVID-19 provides protection to infants, study reveals

A new study from the University of Florida provides more evidence that the breast milk of people vaccinated against COVID-19 provides protection to infants too young to receive the vaccine.

This latest study follows up on findings published in 2021 showing that the breast milk of vaccinated people contained antibodies against SARS-CoV-2, the virus that causes COVID-19. The new study, published in the Journal of Perinatology, analyzed the stool of infants that consumed this breast milk and found SARS-CoV-2 antibodies there as well.

Our first study showed there were SARS-CoV-2 antibodies in the breast milk, but we couldn't say if those antibodies were getting through the babies' gastrointestinal tract and possibly providing protection there."

Joseph Larkin III, senior author of the study and associate professor in the UF/IFAS department of microbiology and cell science

Using a technique called a neutralization assay, the researchers showed that the antibodies found in the infants' stool offered protection against the virus. The assay begins by isolating antibodies from the stool and adding them to a special line of cells that have the kind of receptors the SARS-CoV-2 virus uses to enter the cell. The researchers then introduce a SARS-CoV-2 pseudovirus, which acts like the virus that causes COVID-19 but is safer to use in the lab. The pseudovirus is fluorescent, so when it binds to a cell, the cell lights up.

"We saw that when the antibodies were present, there were fewer fluorescent cells compared to our controls where no antibodies were present," said Lauren Stafford, one of the study's first authors and a UF/IFAS College of Agricultural and Life Sciences doctoral student in Larkin's lab.

"The antibodies run interference and don't let the virus get to the cells," Larkin added.

While the virus that causes COVID-19 is often thought of as mainly affecting the lungs, it can also invade the gut, which is why finding antibodies there is significant, the researchers said.

"The antibodies ingested through breast milk may provide a protective coating in the infants' mouths and gastrointestinal tract," said Dr. Vivian Valcarce Luaces, the study's other first author and a postdoctoral fellowship trainee in neonatology .

The study also measured and tested antibodies found in the mothers' blood plasma and breast milk soon after vaccination and then again about six months later. The researchers found that the antibodies in the plasma and milk of vaccinated people were better able to neutralize the virus, though they also observed that antibody levels decreased at the six-month mark, which other vaccine studies have found as well.

Dr. Josef Neu, one of the study's co-authors and a professor in the UF College of Medicine department of pediatrics, division of neonatology, said the first and second studies together give a more complete picture of how vaccinating against COVID-19 during pregnancy and breastfeeding may be protective for parent and child.

"In our research, we're following the journey of the antibodies, from the time they are produced in mom after vaccination and now through the baby's digestive system. The next question is whether those babies are less likely to get COVID-19," Dr. Neu said.

The researchers say larger studies are needed to answer that question, as this latest study included 37 mothers and 25 infants, a relatively small number of participants.

However, this study adds to a growing body of research revealing how vaccination against COVID-19 during pregnancy and breastfeeding may protect newborns, the researchers say. Currently children under sixth months of age cannot receive the vaccine, so breast milk may be the only avenue for providing immunity.

The study was funded by grants from the Children's Miracle Network and The Gerber Foundation.

The Centers for Disease Control and Prevention recommends COVID-19 vaccination for people who are pregnant, breastfeeding, trying to get pregnant or who may become pregnant in the future. According to the CDC, as of late November 2022, just over 70% of pregnant people in the United States had completed the primary series of COVID-19 vaccines, though only 14% had received the bivalent booster.

Source:
Journal reference:

Stafford, L.S., et al. (2022) Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination. Journal of Perinatology. doi.org/10.1038/s41372-022-01581-5.

Comments

  1. Captain Obvious Captain Obvious Australia says:

    The growing body of evidence being produced by the scientific literature from the raw data doesn't support this argument which at the very least appears to be government sponsored propaganda and at the worst is a cover up puff piece that doesn't mind sacrificing a whole generation for a few extra dollars. Be ashamed of yourselves and start reporting unbiased peer reviewed scientific evidence. Negative efficacy and dramatically increased risk to heart complications and a whole host of illnesses as a result are the only effects these gene therapy shots are providing. Which now as you say is being passed onto a generation that has barely existed in this world via a mechanism that was and remains their only source of guaranteed protection. Well done for decimating the inmate protection of infants across the globe to please your corporate donors.

  2. Eugene melnyck Eugene melnyck Canada says:

    What risks,  heart attacks and other illnesses, now exposed to the newborns? These spike proteins have not been fully studied and are experimental.

  3. Swale 69 Swale 69 United States says:

    The people resposible for this article are more concerned with liberal political correct wokism than actual human life.

  4. John Andrews John Andrews United States says:

    I'd say the infant is being contaminated with the gene therapy.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans